These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37541706)

  • 1. A multilevel health system intervention for virological suppression in adolescents and young adults living with HIV in rural Kenya and Uganda (SEARCH-Youth): a cluster randomised trial.
    Ruel T; Mwangwa F; Balzer LB; Ayieko J; Nyabuti M; Mugoma WE; Kabami J; Kamugisha B; Black D; Nzarubara B; Opel F; Schrom J; Agengo G; Nakigudde J; Atuhaire HN; Schwab J; Peng J; Camlin C; Shade SB; Bukusi E; Kapogiannis BG; Charlebois E; Kamya MR; Havlir D
    Lancet HIV; 2023 Aug; 10(8):e518-e527. PubMed ID: 37541706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care HIV viral load and targeted drug resistance mutation testing versus standard care for Kenyan children on antiretroviral therapy (Opt4Kids): an open-label, randomised controlled trial.
    Patel RC; Oyaro P; Thomas KK; Wagude J; Mukui I; Brown E; Hassan SA; Kinywa E; Oluoch F; Odhiambo F; Oyaro B; Kingwara L; Karauki E; Yongo N; Otieno L; John-Stewart GC; Abuogi LL
    Lancet Child Adolesc Health; 2022 Oct; 6(10):681-691. PubMed ID: 35987208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial incentives for achieving and maintaining viral suppression among HIV-positive adults in Uganda: a randomised controlled trial.
    Thirumurthy H; Ndyabakira A; Marson K; Emperador D; Kamya M; Havlir D; Kwarisiima D; Chamie G
    Lancet HIV; 2019 Mar; 6(3):e155-e163. PubMed ID: 30660594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a differentiated service delivery model on virological failure in adolescents with HIV in Zimbabwe (Zvandiri): a cluster-randomised controlled trial.
    Mavhu W; Willis N; Mufuka J; Bernays S; Tshuma M; Mangenah C; Maheswaran H; Mangezi W; Apollo T; Araya R; Weiss HA; Cowan FM
    Lancet Glob Health; 2020 Feb; 8(2):e264-e275. PubMed ID: 31924539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of universal HIV testing and treatment on socioeconomic wellbeing in rural Kenya and Uganda: a cluster-randomised controlled trial.
    Jakubowski A; Kabami J; Balzer LB; Ayieko J; Charlebois ED; Owaraganise A; Marquez C; Clark TD; Black D; Shade SB; Chamie G; Cohen CR; Bukusi EA; Kamya MR; Petersen M; Havlir DV; Thirumurthy H
    Lancet Glob Health; 2022 Jan; 10(1):e96-e104. PubMed ID: 34919862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
    Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
    Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population levels and geographical distribution of HIV RNA in rural Ugandan and Kenyan communities, including serodiscordant couples: a cross-sectional analysis.
    Jain V; Petersen ML; Liegler T; Byonanebye DM; Kwarisiima D; Chamie G; Sang N; Black D; Clark TD; Ladai A; Plenty A; Kabami J; Ssemmondo E; Bukusi EA; Cohen CR; Charlebois ED; Kamya MR; Havlir DV;
    Lancet HIV; 2017 Mar; 4(3):e122-e133. PubMed ID: 27989576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya.
    Kwarisiima D; Kamya MR; Owaraganise A; Mwangwa F; Byonanebye DM; Ayieko J; Plenty A; Black D; Clark TD; Nzarubara B; Snyman K; Brown L; Bukusi E; Cohen CR; Geng EH; Charlebois ED; Ruel TD; Petersen ML; Havlir D; Jain V
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21673. PubMed ID: 28770596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial.
    Chung MH; McGrath CJ; Beck IA; Levine M; Milne RS; So I; Andersen N; Dross S; Coombs RW; Chohan B; Yatich N; Kiptinness C; Sakr SR; Kiarie JN; Frenkel LM
    Lancet HIV; 2020 Feb; 7(2):e104-e112. PubMed ID: 31818716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial.
    Kityo C; Szubert AJ; Siika A; Heyderman R; Bwakura-Dangarembizi M; Lugemwa A; Mwaringa S; Griffiths A; Nkanya I; Kabahenda S; Wachira S; Musoro G; Rajapakse C; Etyang T; Abach J; Spyer MJ; Wavamunno P; Nyondo-Mipando L; Chidziva E; Nathoo K; Klein N; Hakim J; Gibb DM; Walker AS; Pett SL;
    PLoS Med; 2018 Dec; 15(12):e1002706. PubMed ID: 30513108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Traditional healer-delivered point-of-care HIV testing versus referral to clinical facilities for adults of unknown serostatus in rural Uganda: a mixed-methods, cluster-randomised trial.
    Sundararajan R; Ponticiello M; Lee MH; Strathdee SA; Muyindike W; Nansera D; King R; Fitzgerald D; Mwanga-Amumpaire J
    Lancet Glob Health; 2021 Nov; 9(11):e1579-e1588. PubMed ID: 34678199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for HIV virological non-suppression among adolescents with common mental disorder symptoms in Zimbabwe: a cross-sectional study.
    Simms V; Bernays S; Chibanda D; Chinoda S; Mutsinze A; Beji-Chauke R; Mugurungi O; Apollo T; Sithole D; Verhey R; Weiss HA; Willis N
    J Int AIDS Soc; 2021 Aug; 24(8):e25773. PubMed ID: 34402199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trial.
    Barnabas RV; Szpiro AA; van Rooyen H; Asiimwe S; Pillay D; Ware NC; Schaafsma TT; Krows ML; van Heerden A; Joseph P; Shahmanesh M; Wyatt MA; Sausi K; Turyamureeba B; Sithole N; Morrison S; Shapiro AE; Roberts DA; Thomas KK; Koole O; Bershteyn A; Ehrenkranz P; Baeten JM; Celum C;
    Lancet Glob Health; 2020 Oct; 8(10):e1305-e1315. PubMed ID: 32971053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial.
    Lester RT; Ritvo P; Mills EJ; Kariri A; Karanja S; Chung MH; Jack W; Habyarimana J; Sadatsafavi M; Najafzadeh M; Marra CA; Estambale B; Ngugi E; Ball TB; Thabane L; Gelmon LJ; Kimani J; Ackers M; Plummer FA
    Lancet; 2010 Nov; 376(9755):1838-45. PubMed ID: 21071074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of continuous quality improvement on coverage of antenatal HIV care tests in rural South Africa: Results of a stepped-wedge cluster-randomised controlled implementation trial.
    Yapa HM; De Neve JW; Chetty T; Herbst C; Post FA; Jiamsakul A; Geldsetzer P; Harling G; Dhlomo-Mphatswe W; Moshabela M; Matthews P; Ogbuoji O; Tanser F; Gareta D; Herbst K; Pillay D; Wyke S; Bärnighausen T
    PLoS Med; 2020 Oct; 17(10):e1003150. PubMed ID: 33027246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition to independent care for youth living with HIV: a cluster randomised clinical trial.
    Njuguna IN; Beima-Sofie K; Mburu CW; Mugo C; Itindi J; Onyango A; Neary J; Richardson BA; Oyiengo L; Wamalwa D; John-Stewart G
    Lancet HIV; 2022 Dec; 9(12):e828-e837. PubMed ID: 36309040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial.
    Gross R; Zheng L; La Rosa A; Sun X; Rosenkranz SL; Cardoso SW; Ssali F; Camp R; Godfrey C; Cohn SE; Robbins GK; Chisada A; Wallis CL; Reynolds NR; Lu D; Safren SA; Hosey L; Severe P; Collier AC;
    Lancet HIV; 2015 Jan; 2(1):e12-9. PubMed ID: 26424232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of integrating HIV prevention within sexual reproductive health services with or without peer support among adolescents and young adults in rural KwaZulu-Natal, South Africa (Isisekelo Sempilo): 2 × 2 factorial, open-label, randomised controlled trial.
    Shahmanesh M; Chimbindi N; Busang J; Chidumwa G; Mthiyani N; Herbst C; Okesola N; Dreyer J; Zuma T; Luthuli M; Gumede D; Hlongwane S; Mdluli S; Msane S; Smit T; Molina JM; Khoza T; Behuhuma NO; McGrath N; Seeley J; Harling G; Sherr L; Copas A; Baisley K
    Lancet HIV; 2024 Jul; 11(7):e449-e460. PubMed ID: 38925731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda.
    Koss CA; Havlir DV; Ayieko J; Kwarisiima D; Kabami J; Chamie G; Atukunda M; Mwinike Y; Mwangwa F; Owaraganise A; Peng J; Olilo W; Snyman K; Awuonda B; Clark TD; Black D; Nugent J; Brown LB; Marquez C; Okochi H; Zhang K; Camlin CS; Jain V; Gandhi M; Cohen CR; Bukusi EA; Charlebois ED; Petersen ML; Kamya MR; Balzer LB
    PLoS Med; 2021 Feb; 18(2):e1003492. PubMed ID: 33561143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study.
    Koss CA; Charlebois ED; Ayieko J; Kwarisiima D; Kabami J; Balzer LB; Atukunda M; Mwangwa F; Peng J; Mwinike Y; Owaraganise A; Chamie G; Jain V; Sang N; Olilo W; Brown LB; Marquez C; Zhang K; Ruel TD; Camlin CS; Rooney JF; Black D; Clark TD; Gandhi M; Cohen CR; Bukusi EA; Petersen ML; Kamya MR; Havlir DV;
    Lancet HIV; 2020 Apr; 7(4):e249-e261. PubMed ID: 32087152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.